Insulin resistance in clomiphene responders and non-responders with polycystic ovarian disease and therapeutic effects of metformin

International Journal of Gynecology and Obstetrics

Volumn 75, Issue 1, 2001, Pages 43-50

  Parsanezhad, M E ^a   Alborzi, S ^a   Zarei, A ^a   Dehbashi, S ^a   Omrani, Gh ^a  

^a SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Clomiphene; Insulin; Metformin; Polycystic ovarian disease

Indexed keywords

ANDROGEN; CLOMIFENE; INSULIN; METFORMIN;

ADOLESCENT; ADULT; ANDROGEN BLOOD LEVEL; AREA UNDER THE CURVE; ARTICLE; BASAL METABOLIC RATE; CLINICAL FEATURE; CLINICAL TRIAL; CONCEPTION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG EFFECT; ENDOCRINOLOGY; FEMALE; FEMALE INFERTILITY; HUMAN; HYPERANDROGENISM; HYPERINSULINEMIA; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; MENSTRUAL IRREGULARITY; OVARY POLYCYSTIC DISEASE; OVULATION; PREGNANCY RATE; PRIORITY JOURNAL; UNIVERSITY HOSPITAL;

EID: 0035708055     PISSN: 00207292     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0020-7292(01)00470-2     Document Type: Article

References (25)

1. Metformin and polycystic ovary syndrome
2. Pathogenesis and treatment of PCOS
3. Metformin effect on clinical features, endocrine and metabolic profiles and insulin sensitivity in PCOS: A randomized, double-blind, placebo, controlled 6 months trial followed by open, long-term clinical evaluation
4. Metformin treatment reduces ovarian cytochrome P450C17 response to human chorionic gonadotropin in women with insulin resistance related PCOS
5. Insulin stimulates androgen accumulation of ovarian stroma obtained from women with hyperandrogenism
6. Metformin therapy in polycystic ovary syndrome reduces hyperinsulinemia, insulin resistance, hyper androgenemia and systolic blood pressure, while facilitating normal menses and pregnancy
7. Antiandrogens and insulin action
8. Metformin: A review of its pharmacological properties and therapeutic use in non-insulin dependent diabetes
9. Improvement of insulin sensitivity by metformin treatment does not lower blood pressure of nonobese insulin resistant hypertensive patient with normal glucose tolerance
10. Insulin-lowering therapeutic modalities for polycystic ovary syndrome
11. Ovarian stromal hypertrophy in PCOS
12. Serum insulin in clomiphene responders and nonresponders with PCOD
13. Decreased serum leptin concentrations during metformin therapy in obese women with PCOD
14. Therapeutic effects of metformin on insulin resistance and hyperandrogenism in PCOS
15. Effect of metformin on spontaneous and clomiphene induced ovulation in PCOS
16. Lean women with PCOS respond to insulin reduction with decreases in ovarian P450C17 activity and serum androgen
17. Can metformin reduce insulin resistance in polycystic ovary syndrome?
18. The treatment of insulin resistance does not improve adrenal cytochrome P450C17 enzyme dysregulation in PCOS
19. Menstrual cyclicity after metformin therapy in PCOS
20. Insulin secretory defects in polycystic ovary syndrome
21. Insulin action in the normal and polycystic ovary
22. Polycystic ovary syndrome: Lack of hypertension despite profound insulin resistance
23. Metformin therapy improves the menstrual pattern with minimal endocrine and metabolic effect in women with PCOS
24. Effect of metformin on adrenal steroidogenesis in women with polycystic ovary syndrome